Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10320796rdf:typepubmed:Citationlld:pubmed
pubmed-article:10320796lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0026844lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10320796lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:10320796pubmed:issue1-2lld:pubmed
pubmed-article:10320796pubmed:dateCreated1999-7-7lld:pubmed
pubmed-article:10320796pubmed:abstractTextWe have previously reported that in cultured rat vascular smooth muscle cells (VSMCs), neurotrophin-3 (NT-3) gene expression was suppressed by TPA (12-O-tetradecanoyl phorbol-13-acetate), which induces an AP-1 transcription factor. In the present study, to clarify the mechanism for TPA-mediated downregulation of NT-3 gene expression, effects of cycloheximide and dexamethasone (Dex) on the TPA-mediated downregulation were examined in VSMCs. Pretreatment with cycloheximide, an inhibitor of protein synthesis, or simultaneous treatment with Dex, an inhibitor of AP-1, suppressed the TPA-mediated downregulation of NT-3 gene expression. Furthermore, co-transfection of c-fos and c-jun expression vectors into VSMCs resulted in decrease in the NT-3 gene expression. The present findings suggest that TPA-induced AP-1 de novo synthesis causes the downregulation of NT-3 gene expression in VSMCs.lld:pubmed
pubmed-article:10320796pubmed:languageenglld:pubmed
pubmed-article:10320796pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:citationSubsetIMlld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10320796pubmed:statusMEDLINElld:pubmed
pubmed-article:10320796pubmed:monthMaylld:pubmed
pubmed-article:10320796pubmed:issn0169-328Xlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:MiyataSSlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:NakamuraYYlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:FukamachiKKlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:SenbaEElld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:HamadaMMlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:NemotoKKlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:UeyamaTTlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:SekimotoMMlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:DegawaMMlld:pubmed
pubmed-article:10320796pubmed:authorpubmed-author:NemotoFFlld:pubmed
pubmed-article:10320796pubmed:copyrightInfoCopyright 1999 Elsevier Science B.V.lld:pubmed
pubmed-article:10320796pubmed:issnTypePrintlld:pubmed
pubmed-article:10320796pubmed:day7lld:pubmed
pubmed-article:10320796pubmed:volume68lld:pubmed
pubmed-article:10320796pubmed:ownerNLMlld:pubmed
pubmed-article:10320796pubmed:authorsCompleteYlld:pubmed
pubmed-article:10320796pubmed:pagination186-9lld:pubmed
pubmed-article:10320796pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:meshHeadingpubmed-meshheading:10320796...lld:pubmed
pubmed-article:10320796pubmed:year1999lld:pubmed
pubmed-article:10320796pubmed:articleTitleA possible mechanism of TPA-mediated downregulation of neurotrophin-3 gene expression in rat cultured vascular smooth muscle cells.lld:pubmed
pubmed-article:10320796pubmed:affiliationLaboratory of Health Science, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka, 422-8526, Japan. nemoto@ys7.u-shizuoka-ken.ac.jplld:pubmed
pubmed-article:10320796pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10320796pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed